Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Other Working Capital Changes: 2023-2025

Historic Other Working Capital Changes for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to -$4.0 million.

  • Compass Therapeutics' Other Working Capital Changes fell 154.33% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year decrease of 249.28%. This contributed to the annual value of $4.9 million for FY2024, which is 171.83% up from last year.
  • Per Compass Therapeutics' latest filing, its Other Working Capital Changes stood at -$4.0 million for Q3 2025, which was up 35.81% from -$6.3 million recorded in Q2 2025.
  • In the past 5 years, Compass Therapeutics' Other Working Capital Changes registered a high of $5.5 million during Q1 2025, and its lowest value of -$6.3 million during Q2 2025.
  • In the last 3 years, Compass Therapeutics' Other Working Capital Changes had a median value of -$1.4 million in 2023 and averaged -$609,909.
  • Examining YoY changes over the last 5 years, Compass Therapeutics' Other Working Capital Changes showed a top increase of 485.58% in 2025 and a maximum decrease of 226.21% in 2025.
  • Quarterly analysis of 3 years shows Compass Therapeutics' Other Working Capital Changes stood at -$1.5 million in 2023, then soared by 136.89% to $539,000 in 2024, then crashed by 154.33% to -$4.0 million in 2025.
  • Its Other Working Capital Changes was -$4.0 million in Q3 2025, compared to -$6.3 million in Q2 2025 and $5.5 million in Q1 2025.